Final-Program-ATS-2023-AP.vp

MONDAY • MAY 22

199

2:45 PRO: Adenotonsillectomy Should Be Used for the Treatment of Mild Sleep-Disordered Breathing in Children S.S. Redline, MD, MPH, Boston, MA 2:55 CON: Adenotonsillectomy Should Be Used for the Treatment of Mild Sleep-Disordered Breathing in Children S.L. Verhulst, MD, PhD, MSc, Edegem, Belgium 3:05 Discussion: Adenotonsillectomy for the Treatment of Mild Sleep-Disordered Breathing in Children R. Amin, MD, Toronto, Canada 3:10 PRO: Drug-Induced Sleep Endoscopy Should be Used for Etiology of Residual OSA Following Adenotonsillectomy C. Heubi, MD, Cincinnati, OH 3:20 CON: Drug-Induced Sleep Endoscopy Should Be Used for Etiology of Residual OSA Following Adenotonsillectomy Z. Ehsan, MD, Kansas City, MO 3:30 Discussion: Drug-Induced Sleep Endoscopy for Evaluation of the Etiology of Residual OSA Following Adenotonsillectomy. C.M. Cielo, DO, Philadelphia, PA 3:35 Future Directions R. Amin, MD, Toronto, Canada

CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5

B87 CONTROVERSIES IN PEDIATRIC OBSTRUCTIVE SLEEP APNEA: A PRO/CON DEBATE Assemblies on Pediatrics; Sleep and Respiratory Neurobiology 2:15 PM - 3:45 PM Marriott Marquis Washington Marquis Ballroom Salon 5 (Level M2) Target Audience Clinicians and researchers who care for and study children with obstructive sleep apnea, including sleep medicine physicians, pediatric pulmonologists, and allied health professionals Objectives At the conclusion of this session, the participant will be able to: • inform the clinicians and researchers about specific areas of debate in the evaluation and management of obstructive sleep apnea in children • apply state of the science to help the audience decide on appropriate uses of diagnostic and treatment modalities related to pediatric obstructive sleep apnea • identify key gaps for conditions mentioned in objectives 1 and 2 that should inform future research There has been substantial new clinical research related to the evaluation and management of obstructive sleep apnea in children since clinical practice guidelines were most recently published. As a result, a number of controversies exist in this area, including 1) home sleep apnea testing for the evaluation of OSA in children, 2) adenotonsillectomy for treatment of mild sleep-disordered breathing in children, and 3 the use of drug-induced sleep endoscopy for etiology of residual OSA following adenotonsillectomy. In this session, a panel of experts will review the state of the science and evidence for these topics in a pro/con format. Chairing: C.M. Cielo, DO, Philadelphia, PA R. Amin, MD, Toronto, Canada 2:15 Introduction R. Amin, MD, Toronto, Canada 2:20 PRO: Home Sleep Apnea Testing Should Be Expanded to Include Children I. Tapia, MD, MS, Philadelphia, PA 2:30 CON: Home Sleep Apnea Testing Should Be Expanded to Include Children R. Bhattacharjee, MD, San Diego, CA 2:40 Discussion: Home Sleep Apnea Testing for the

TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5

B88

LEAPS AND BOUNDS: REDUCING HEALTHCARE’S CARBON FOOTPRINT

Assemblies on Environmental, Occupational and Population Health; Critical Care; Nursing; Health Policy Committee 2:15 PM - 3:45 PM Walter E. Washington Convention Center Room 150 A-B (Street Level) Target Audience Researchers focused on healthcare delivery and/or environmental/occupational exposures, those with clinical, research or administrative responsibilities, and policy makers who focus on environmental regulations and healthcare delivery Objectives At the conclusion of this session, the participant will be able to: • define the healthcare industry’s contribution to emissions and climate change • understand and apply interventions at the individual and system levels to reduce, eliminate, or reverse healthcare’s environmental impact and emissions

Evaluation of OSA in Children C.M. Cielo, DO, Philadelphia, PA

ATS 2023 • Washington, DC